Commonwealth Equity Services
SLNO

Commonwealth Equity Services’s Soleno Therapeutics SLNO Stock Holding History

Commonwealth Equity Services’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,667
Closed -$18K – 3756
2022
Q2 		$18K Hold
6,667
– – ﹤0.01% 3578
2022
Q1 		$22K Buy
+6,667
New +$34.5K ﹤0.01% 3652

Other funds holding SLNO

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Commonwealth Equity Services's SLNO Position: Q3 2022 in Review

Commonwealth Equity Services sold out of Soleno Therapeutics (SLNO) in Q3 2022, closing a stake of 6,667 shares — an estimated $18K sold.

Commonwealth Equity Services first reported a position in SLNO in Q1 2022 and held it in 2 quarters. The position peaked at $22K in Q1 2022. 22 funds tracked by Wall St. Rank hold SLNO as of Q3 2022.

  • Commonwealth Equity Services reported no remaining Soleno Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 6,667 Soleno Therapeutics shares in Q3 2022, an estimated $18K.
  • Commonwealth Equity Services first reported a position in Soleno Therapeutics in Q1 2022 and held it in 2 quarters.
  • Commonwealth Equity Services's Soleno Therapeutics position peaked at $22K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q3 2022.

Based on Commonwealth Equity Services's 13F filing for Q3 2022, filed 14 Nov 2022.